OTC Markets OTCQB - Delayed Quote USD

Guided Therapeutics, Inc. (GTHP)

0.1900
-0.0100
(-5.00%)
At close: June 11 at 8:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Mark L. Faupel Ph.D. CEO, President, COO, Acting CFO, Secretary & Director 206.77k -- 1955

Guided Therapeutics, Inc.

5835 Peachtree Corners East
Suite B
Peachtree Corners, GA 30092
United States
770 242 8723 https://www.guidedinc.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
4

Description

Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the marketing and sale of LuViva, an advanced cervical scan non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.

Corporate Governance

Guided Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 12, 2025 at 8:00 PM UTC - August 18, 2025 at 8:00 PM UTC

Guided Therapeutics, Inc. Earnings Date

Recent Events

May 15, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

March 31, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

December 23, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 27, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

March 28, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

November 13, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 10, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers